Deepinder Goyal Fuels Longevity with $25 Million in 'Continue Research'

Deepinder Goyal announced a $25 million investment in 'Continue Research', a venture dedicated to advancing research on health and human longevity. Started two years ago, the initiative aims to extend healthy human function, encouraging long-term decision-making by society.

Deepinder Goyal, the founder and CEO of Eternal, declared on Friday that he will allocate $25 million to boost 'Continue Research', a project committed to exploring breakthroughs in health and longevity.

In a comprehensive post on X, Goyal articulated the mission of 'Continue Research', an initiative he initiated two years ago, which seeks to uncover fundamental insights into human aging and biological processes.

The long-term ambition of the project is to enhance healthy human function, helping society adopt a long-term outlook in decision-making. Goyal emphasized that the $25 million fund, exclusively supported by him, aims to back worldwide researchers willing to ask unconventional questions, moving beyond temporary solutions.

(With inputs from agencies.)